Target Price | $329.31 |
Price | $316.67 |
Potential | 3.99% |
Number of Estimates | 26 |
26 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $329.31. This is 3.99% higher than the current stock price. The highest price target is $420.00 32.63% , the lowest is $194.00 38.74% . | |
A rating was issued by 34 analysts: 18 Analysts recommend Lululemon Athletica to buy, 13 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 3.99% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
28 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.2b . This is 5.93% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.4b 7.49% , the lowest is $10.7b 1.44% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.2b | 5.93% |
2027 | $12.1b | 7.61% |
2028 | $13.0b | 7.38% |
2029 | $13.8b | 6.17% |
2030 | $14.8b | 7.33% |
24 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.0b . This is 19.70% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.1b 24.17% , the lowest is $2.7b 8.03% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.5b | 13.55% |
---|---|---|
2026 | $3.0b | 19.58% |
2027 | $3.2b | 6.38% |
2028 | $3.5b | 8.38% |
2029 | $3.8b | 8.76% |
2030 | $4.1b | 9.92% |
2025 | 23.72% | 3.16% |
---|---|---|
2026 | 26.78% | 12.88% |
2027 | 26.47% | 1.16% |
2028 | 26.72% | 0.94% |
2029 | 27.37% | 2.43% |
2030 | 28.03% | 2.41% |
10 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.9b . This is 4.00% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.0b 7.97% , the lowest is $1.7b 8.68% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 17.06% |
---|---|---|
2026 | $1.9b | 4.00% |
2027 | $2.1b | 9.52% |
2028 | $2.1b | 3.78% |
2029 | $2.7b | 27.76% |
2030 | $3.0b | 11.25% |
2025 | 17.14% | 6.35% |
---|---|---|
2026 | 16.83% | 1.80% |
2027 | 17.12% | 1.72% |
2028 | 16.55% | 3.33% |
2029 | 19.92% | 20.36% |
2030 | 20.64% | 3.61% |
10 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $14.93 . This is 0.20% higher than earnings per share in the financial year 2025. The highest EPS forecast is $15.50 4.03% , the lowest is $13.11 12.01% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $14.93 | 1.98% |
2027 | $16.35 | 9.51% |
2028 | $16.97 | 3.79% |
2029 | $21.68 | 27.75% |
2030 | $24.12 | 11.25% |
Current | 21.25 | 12.25% |
---|---|---|
2026 | 21.21 | 0.20% |
2027 | 19.37 | 8.68% |
2028 | 18.66 | 3.67% |
2029 | 14.61 | 21.70% |
2030 | 13.13 | 10.13% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 3.36 and an P/S ratio of 3.54 .
This results in the following potential growth metrics and future valuations:
Current | 3.56 | 0.85% |
---|---|---|
2026 | 3.36 | 5.62% |
2027 | 3.12 | 7.07% |
2028 | 2.91 | 6.87% |
2029 | 2.74 | 5.81% |
2030 | 2.55 | 6.83% |
Current | 3.75 | 0.59% |
---|---|---|
2026 | 3.54 | 5.59% |
2027 | 3.29 | 7.07% |
2028 | 3.06 | 6.87% |
2029 | 2.88 | 5.81% |
2030 | 2.69 | 6.83% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
Citigroup |
Neutral
➜
Neutral
|
Unchanged | May 29 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | May 28 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 12 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 30 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 28 2025 |
Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Apr 22 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 14 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
May 29 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
May 28 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
May 12 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 30 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 28 2025 |
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Apr 22 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.